Responsibilities such as equipment calibration and quality assurance (QA), patient-specific QA, treatment plan checks, weekly chart checks, and patient-specific measurements are characterized as "routine" and "checking" activities not generally requiring the expertise of the medical physicist. We disagree. Tasks performed over and over, day after day are correctly described as "routine," a description that refers to their temporal repetition but should not be taken to denigrate the intellectual effort and expertise that is used for each unique instance. Medical physicists should not be at risk for replacement by individuals with more limited training if we, at each of these "routine" endeavors, bring to bear the full spectrum of our training and expertise, unrivaled by anyone else on the radiation oncology team. After the fact, one could identify particular tasks or steps for a particular patient that could have been undertaken by another individual on the team, but it is not possible to identify, a priori, all the possible failure modes that a properly educated and trained medical physicist might identify in a sequence of technical or clinical reviews.
think clinical medical physicists should not focus on quality and safety? The answer is found deep in the editorial, following a summary of the authors' impression of the routine tasks performed by oncology medical physicists as well as the associated value. We begin by offering an alternative understanding of the clinical contributions of the oncology medical physicist and then address the proposals of Pawlicki and Mundt for a revised path for the future of our profession. We find much to agree with in their editorial, but believe the substance of the arguments to be fundamentally flawed, without the likelihood of either adoption, or success if adopted.
Let us look at some of the activities of clinical medical physicists in radiation oncology, following the outline of Pawlicki and Mundt.
Responsibilities such as equipment calibration and quality assurance (QA), patient-specific QA, treatment plan checks, weekly chart checks, and patient-specific measurements are characterized as "routine" and "checking" activities not generally requiring the expertise of the medical physicist. We disagree. Tasks performed over and over, day after day are correctly described as "routine," a description that refers to their temporal repetition but should not be taken to denigrate the intellectual effort and expertise that is used for each unique instance. Medical physicists should not be at risk for replacement by individuals with more limited training if we, at each of these "routine" endeavors, bring to bear the full spectrum of our training and expertise, unrivaled by anyone else on the radiation oncology team. After the fact, one could identify particular tasks or steps for a particular patient that could have been undertaken by another individual on the team, but it is not possible to identify, a priori, all the possible failure modes that a properly educated and trained medical physicist might identify in a sequence of technical or clinical reviews.
It is the ability of the medical physicist to integrate the physical, anatomic, and clinical aspects of each individual patient treatment sequence that brings value to the process.
We agree with Pawlicki and Mundt that automation of QA, increased reliability of equipment, etc., will certainly make much of the work we currently perform less time-consuming or even unnecessary. This is not a new phenomenon in our profession. One of us can remember digitizing patient contours (taken by solder wire) by typing in hundreds of (x,y) coordinates into a teletype console to be used by a remote radiation therapy planning system. Current technologies allow us to enter spatial (and density) information with millions more data points in a few seconds. Do we now have hours left over with nothing to do? No, we spend even more time with tasks such as preparing stereotactic isodose plans, consulting with radiation oncologists, neurosurgeons, pulmonologists, and others on the details of the proposed treatments and then implementing them on the treatment machines. Earlier effort at performing the dosimetric plan verification associated with intensity modulated radiation therapy (IMRT) involved a very lengthy process using film for each of 6-9 fields, scanning densitometers, H&D corrections, rigid processor quality control, and image analysis. Fast-forward to today, we have diode-and EPID-based techniques, but our profession continues to advance in value. An increase in complexity and automation often leads to an increase in the need for professional expertise for the big picture, not a decrease. 3 We will need to continue to adapt "routine" QA to meet changing technology. New techniques for new imaging, planning, and delivery systems will be necessary and will require the efforts of medical physicists to design, test, and implement these procedures.
While others will do some tests, we will perform some ourselves and personally review and analyze the entire spectrum of testing, assisted by automated techniques. QA tasks, and benchmarks for existing technology will be adjusted in light of current design and clinical implementation. 4 Some additional, specific examples:
One of the routine duties for clinical medical physicists is to check patient-specific charts. This includes both plan review prior to the first treatment and ongoing weekly checks. We believe these activities are very important for the quality and safety of patient care. On many
occasions, physicists could find issues with the treatment plan such as missing couch or omitting density overwrite for contrast agent. Such catches can certainly improve the quality of the treatment plan with more accurate dose calculations. In less frequent cases, physicists may detect even bigger errors like wrong image set for planning, which otherwise could jeopardize the patient's safety. These independent plan reviews are critical to the quality and safety of patient care. Literature has shown that many potential errors are caught during the initial and ongoing chart review by clinical medical physicists. 5 Some may argue that these plan review activities can be replaced by automation and artificial intelligence (AI), and that the role of clinical medical physicists therefore becomes less important for the quality and safety of patient care. Indeed, automation and AI are increasingly adopted in radiation oncology for tasks such as contouring, autoplanning, and plan checks. We do not believe, however, that automation would replace clinical medical physicists even for some of the simple tasks that computers can perform. Oftentimes, the task needs to be cus- tify that physicist's involvement is essential for gated SBRT treatments of liver cancer using the Calypso technology. 6 Many steps are required to interact among the various control systems and the clinical medical physicist is essentially the "orchestra director" for the entire treatment delivery team.
As to other, clinically based changes to the practice of medical physics, we agree wholeheartedly with Pawlicki and Mundt that "Physicists think differently than medically trained healthcare professionals such as radiation oncologists or nurses." (It is this proclivity for a different mode of thinking and possession of a different set of technical and scientific skills that brings value to the medical physics endeavor in the clinic.) They follow this thought with the unsupported assertion that "Unfortunately, the physicist's unique perspective is not being utilized because most of their time is spent checking the work of others." In our experience, that is not the case.
Even those activities that have a "checking" component, such as isodose plan review or weekly chart checks, also involve an analysis of the application of technology to the care process for an individual patient. We also agree that patients will benefit from increased approval; but we note that the medical physicist prior to administration must approve every treatment plan in our clinics. We see no patient benefit to removing the physician from the approval process. We look forward to the implementation of a different, more clinically oriented training program for medical physicists that will lead to an increase in the direct contact between the patient and the medical physicist. Many of us are experiencing this in our clinics today and are hopeful that proliferation of that practice pattern will continue. We see no reason to denigrate the importance of the quality and safety work by the medical physicist to achieve this goal.
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